Thompson Investment Management Inc. Grows Holdings in Concentrix Corporation $CNXC

Thompson Investment Management Inc. lifted its stake in Concentrix Corporation (NASDAQ:CNXC) by 36.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 216,154 shares of the company’s stock after acquiring an additional 58,251 shares during the quarter. Concentrix accounts for 1.1% of Thompson Investment Management Inc.’s investment portfolio, making the stock its 29th largest position. Thompson Investment Management Inc. owned 0.35% of Concentrix worth $8,988,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently made changes to their positions in the stock. Huntington National Bank raised its position in Concentrix by 6,011.1% in the third quarter. Huntington National Bank now owns 550 shares of the company’s stock valued at $25,000 after purchasing an additional 541 shares during the period. Quent Capital LLC purchased a new position in shares of Concentrix during the third quarter worth $29,000. Larson Financial Group LLC grew its stake in shares of Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after buying an additional 479 shares in the last quarter. Geneos Wealth Management Inc. grew its stake in shares of Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after buying an additional 522 shares in the last quarter. Finally, Rothschild Investment LLC raised its holdings in shares of Concentrix by 14,980.0% in the 3rd quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock valued at $35,000 after buying an additional 749 shares during the period. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Insider Activity at Concentrix

In related news, CEO Christopher A. Caldwell acquired 1,000 shares of the stock in a transaction dated Thursday, January 29th. The stock was acquired at an average cost of $37.07 per share, with a total value of $37,070.00. Following the completion of the transaction, the chief executive officer owned 362,075 shares in the company, valued at $13,422,120.25. This represents a 0.28% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.90% of the company’s stock.

Key Concentrix News

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Management emphasized AI-led growth opportunities on the Q1 earnings call and highlighted strategic initiatives that could boost margins over time. Concentrix Earnings Call Highlights AI-Led Growth
• Neutral Sentiment: Q1 revenue came in roughly in line or slightly above expectations and grew year-over-year, showing demand resilience even as profitability disappointed; the full earnings-call transcript is available for detail on guidance and cost actions. Concentrix Q1 2026 earnings call transcript
• Neutral Sentiment: Several market roundups listed CNXC among stocks trading down after the print, reflecting broad market reaction rather than company-specific news only. Driven Brands, Cogent, Concentrix, Arlo Technologies, and Planet Labs Stocks Trade Down
• Negative Sentiment: CNXC missed on EPS (market coverage highlights a sizable EPS miss in headlines), which is the primary driver of the selloff as investors punish the near-term profitability miss. Concentrix Corporation Just Missed EPS By 63%
• Negative Sentiment: Multiple brokerages lowered expectations and issued pessimistic forecasts/price-target cuts following the quarter (Barrington Research, Robert W. Baird, Canaccord Genuity), increasing sell-side pressure. Barrington Research Has Lowered Expectations for Concentrix
• Negative Sentiment: Coverage pieces report shares falling and CNXC hitting a new one-year low after the earnings miss, a sign of quantitatively increased downside interest and weaker near-term sentiment. Concentrix Sets New 1-Year Low After Earnings Miss
• Negative Sentiment: News outlets summarized the stock decline as “disappointing earnings” with shares down several percent, reinforcing the negative momentum. Shares Down on Disappointing Earnings

Concentrix Price Performance

Shares of NASDAQ CNXC opened at $26.42 on Monday. The stock has a market cap of $1.62 billion, a P/E ratio of -1.23, a PEG ratio of 0.33 and a beta of 0.50. The business’s fifty day simple moving average is $34.38 and its 200-day simple moving average is $39.78. Concentrix Corporation has a 12-month low of $24.27 and a 12-month high of $64.74. The company has a current ratio of 1.18, a quick ratio of 1.40 and a debt-to-equity ratio of 1.43.

Concentrix (NASDAQ:CNXC) last released its earnings results on Tuesday, March 24th. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.65 by ($0.04). Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The company had revenue of $2.50 billion for the quarter, compared to analyst estimates of $2.49 billion. During the same period in the previous year, the firm earned $2.79 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. As a group, equities analysts predict that Concentrix Corporation will post 10.11 EPS for the current fiscal year.

Concentrix Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 5th. Stockholders of record on Friday, April 24th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 5.5%. The ex-dividend date is Friday, April 24th. Concentrix’s dividend payout ratio (DPR) is presently -6.68%.

Analysts Set New Price Targets

Several research firms recently issued reports on CNXC. Weiss Ratings lowered Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Barrington Research dropped their target price on Concentrix from $62.00 to $38.00 and set an “outperform” rating for the company in a research report on Wednesday, March 25th. Robert W. Baird cut their price target on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 25th. Canaccord Genuity Group reduced their price target on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research report on Wednesday, March 25th. Finally, Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $48.50.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.